blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1698630

EP1698630 - New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  27.11.2020
Database last updated on 02.08.2024
FormerThe patent has been granted
Status updated on  05.03.2017
Most recent event   Tooltip27.11.2020Revocation of patentpublished on 30.12.2020  [2020/53]
Applicant(s)For all designated states
Alfasigma S.p.A.
Via Ragazzi del '99, 5
40133 Bologna / IT
[N/P]
Former [2018/35]For all designated states
Alfasigma S.p.A.
Via Ragazzi del '99 n. 5
40133 Bologna / IT
Former [2017/38]For all designated states
Alfasigma S.p.A.
Viale Sarca, 223
20126 Milano / IT
Former [2006/36]For all designated states
ALFA WASSERMANN S.p.A.
Contrada Sant'Emidio s.n.c.
65020 Alanno Scalo (Pescara) / IT
Inventor(s)01 / Viscomi, Giuseppe Claudio
Via XXV Aprile, 17
40037 Sasso Marconi, Bologna / IT
02 / Campana, Manuela
Via Valdossola, 26
40134 Bologna / IT
03 / Confortini, Donatella
Via A. Gramsci, 43
40012 Calderara di Reno, Bologna / IT
04 / Barbanti, Maria Miriam
Mura di Porta d'Azeglio, 4
40136 Bologna / IT
05 / Braga, Dario
Via Wiligelmo 7
40133 Bologna / IT
 [2006/42]
Former [2006/36]01 / Viscomi, Guiseppe Claudio
Via XXV Aprile, 17
40037 Sasso Marconi, Bologna / IT
02 / Campana, Manuela
Via Valdossola, 26
40134 Bologna / IT
03 / Confortini, Donatella
Via A. Gramsci, 43
40012 Calderara di Reno, Bologna / IT
04 / Barbanti, Maria Miriam
Mura di Porta d'Azeglio, 4
40136 Bologna / IT
05 / Braga, Dario
Via Wiligelmo 7
40133 Bologna / IT
Representative(s)Hiebl, Inge Elisabeth, et al
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[2014/36]
Former [2011/17]Hiebl, Inge Elisabeth, et al
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Former [2008/02]Bianchetti, Giuseppe
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Former [2006/36]Hiebl, Inge Elisabeth, et al
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date05004695.203.03.2005
[2006/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1698630
Date:06.09.2006
Language:EN
[2006/36]
Type: A8 Corrected patent application 
No.:EP1698630
Date:25.10.2006
[2006/43]
Type: B1 Patent specification 
No.:EP1698630
Date:03.09.2014
Language:EN
[2014/36]
Search report(s)(Supplementary) European search report - dispatched on:EP03.08.2005
ClassificationIPC:C07D498/22, A61K31/395, A61P31/04
[2006/36]
CPC:
C07D491/22 (EP,US); C07D498/22 (EP,NO,US); A61K31/44 (KR);
A61K31/395 (NO); A61K31/437 (EP,US); A61K9/0053 (US);
A61P31/00 (EP); A61P31/04 (EP); C07D499/64 (KR);
C07B2200/13 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/36]
Extension statesAL03.11.2006
BA03.11.2006
HR03.11.2006
LV03.11.2006
MK03.11.2006
YU03.11.2006
TitleGerman:Neue polymorphe Formen von Rifaximin, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel[2014/36]
English:New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations[2006/36]
French:Nouvelles formes polymorphes du rifaximin, procédés pour leur préparation et leur utilisation en tant que médicaments[2014/36]
Former [2006/36]Polymorphe Formen von rifaximin, Verfharen zu ihrer Herstellung und ihre Verwendung als Arzneimittel
Former [2006/36]Formes polymorphes du rifaximin procédé pour leur préparation et leur utilisation en tant que médicaments
Examination procedure03.11.2006Examination requested  [2006/51]
09.10.2007Despatch of a communication from the examining division (Time limit: M04)
18.02.2008Reply to a communication from the examining division
07.05.2009Despatch of a communication from the examining division (Time limit: M04)
01.09.2009Reply to a communication from the examining division
19.01.2011Despatch of a communication from the examining division (Time limit: M04)
23.05.2011Reply to a communication from the examining division
31.07.2013Despatch of a communication from the examining division (Time limit: M04)
13.11.2013Reply to a communication from the examining division
22.05.2014Communication of intention to grant the patent
22.07.2014Fee for grant paid
22.07.2014Fee for publishing/printing paid
22.07.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.10.2007
Opposition(s)Opponent(s)01  03.06.2015  09.06.2015  ADMISSIBLE
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl / AT
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 [N/P]
Former [2015/28]
Opponent(s)01  03.06.2015   
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl / AT
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Mauerkircherstrasse 45
81679 München / DE
13.07.2015Invitation to proprietor to file observations on the notice of opposition
23.03.2016Reply of patent proprietor to notice(s) of opposition
09.02.2017Date of oral proceedings
06.03.2017Despatch of minutes of oral proceedings
06.03.2017Despatch of communication that the patent will be revoked
03.11.2020Legal effect of revocation of patent [2020/53]
Appeal following opposition18.04.2017Appeal received No.  T1024/17
06.07.2017Statement of grounds filed
03.11.2020Result of appeal procedure: appeal of the proprietor withdrawn
Fees paidRenewal fee
27.03.2007Renewal fee patent year 03
26.03.2008Renewal fee patent year 04
26.03.2009Renewal fee patent year 05
30.03.2010Renewal fee patent year 06
28.03.2011Renewal fee patent year 07
26.03.2012Renewal fee patent year 08
26.03.2013Renewal fee patent year 09
25.03.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY03.09.2014
MC03.09.2014
[2015/46]
Former [2015/11]CY03.09.2014
Documents cited:Search[X]US4341785  (MARCHI EGIDIO, et al) [X] 1-11 * column 4, line 60 - column 4, line 66 * * column 6, line 13 - column 6, line 31; example 6 *;
 [XD]EP0161534  (ALFA FARMACEUTICI SPA [IT]) [XD] 1-11 * examples 1,4,6-14 *;
 [E]WO2005044823  (ALFA WASSERMANN SPA [IT], et al) [E] 1-11* the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.